Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study

Journal of Medical Screening

Volumn 22, Issue 2, 2015, Pages 76-82

  Denis, Bernard ^a   Gendre, Isabelle ^a   Perrin, Philippe ^a  

^a Association for colorectal cancer screening in Alsace   (France)

Author keywords

colonoscopy; colorectal neoplasms diagnosis; early detection of cancer methods; mass screening methods; occult blood

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GUAIAC;

COHORT ANALYSIS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FEMALE; FRANCE; HUMAN; MALE; OCCULT BLOOD; PROCEDURES;

COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FRANCE; GUAIAC; HUMANS; INDICATORS AND REAGENTS; MALE; OCCULT BLOOD;

EID: 84952773808     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314567795     Document Type: Article

References (39)

1. J.FerlayD.M.ParkinE.Steliarova-Foucher. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer2010; 46: 765–81.
2. R.SiegelD.NaishadhamA.Jemal. Cancer statistics, 2013. CA Cancer J Clin2013; 63: 11–30.
3. J.S.MandelJ.H.BondT.R.Church. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med1993; 328: 1365–71.
4. O.KronborgC.FengerJ.OlsenO.D.JørgensenO.Søndergaard. Randomised study of screening for colorectal cancer with faecal-occult-blood. Lancet1996; 348: 1467–71.
5. J.D.HardcastleJ.O.ChamberlainM.H.E.Robinson. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet1996; 348: 1472–7.
6. E.LindholmH.BrevingeE.Haglind. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg2008; 95: 1029–36.
7. H.GoulardM.Boussac-ZarebskaR.Ancelle-ParkJ.Bloch. French colorectal cancer screening pilot programme: results of the first round. J Med Screen2008; 15: 143–8.
8. B.DenisM.RuetschP.Strentz. Short-term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut2007; 56: 1579–84.
9. J.FaivreV.DancourtC.Lejeune. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology2004; 126: 1674–80.
10. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ2004; 329: 133–7.
11. R.J.SteeleP.L.McClementsG.Libby. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut2009; 58: 530–5.
12. S.M.MossC.CampbellJ.Melia. Performance measures in three rounds of the English bowel cancer screening pilot. Gut2012; 61: 101–7.
13. G.LibbyD.H.BrewsterP.L.McClements. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer2012; 107: 255–9.
14. M.PerisJ.A.EspinàsL.Muñoz. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen2007; 14: 81–6.
15. N.MalilaT.PalvaO.Malminiemi. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen2011; 18: 18–23.
16. M.KatičićN.AntoljakM.Kujundžić. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). World J Gastroenterol2012; 18: 4300–7.
17. Blom J, Kilpeläinen S, Hultcrantz R, Törnberg S. Five-year experience of organized colorectal cancer screening in a Swedish population – increased compliance with age, female gender, and subsequent screening round. J Med Screen 2014 [Epub ahead of print]
18. H. Goulard, D. Jezewski-Serra, N. Duport, Salines E, Danzon A. Évaluation épidémiologique du dépistage organisé du cancer colorectal en France. Résultats des programmes pilotes au-delà de la première campagne [http://www.invs.sante.fr/]
19. InVS [http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Cancers/Evaluation-des-programmes-de-depistage-des-cancers/Evaluation-du-programme-de-depistage-du-cancer-colorectal/Indicateurs-d-evaluation/Taux-de-participation-au-programme-de-depistage-organise-du-cancer-colorectal-2012-2013
20. Z.F.GelladK.M.StechuchakD.A.Fisher. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol2011; 106: 1125–34.
21. A.H.van RoonS.L.GoedeM.van Ballegooijen. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut2013; 62: 409–15.
22. R.J.SteeleP.L.McClementsG.LibbyA.CareyC.G.Fraser. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis2013; 16: 28–32.
23. M.A.TaziJ.FaivreF.DassonvilleJ.LamourC.MilanG.Durand. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen1997; 4: 147–51.
24. C.LejeuneP.ArveuxV.DancourtS.BéjeanC.Bonithon-KoppJ.Faivre. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer. Int J Technol Assess Health Care2004; 20: 434–9.
25. P.HewitsonP.GlasziouE.WatsonB.TowlerL.Irwig. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol2008; 103: 1541–9.
26. Haut-Rhin Cancer Registry [http://www.arer68.org]
27. V.S.BensonW.S.AtkinJ.Green. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer2012; 130: 2961–73.
28. J.L.BulliardM.GarciaJ.BlomC.SenoreV.MaiC.Klabunde. Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer. Eur J Cancer2014; 50: 434–46.
29. B.LevinD.A.LiebermanB.McFarland. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology2008; 134: 1570–95.
30. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med2008; 149: 627–37.
31. Halloran SP, Launoy G, Zappa M; International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Faecal occult blood testing. Endoscopy 2012;44Suppl 3:SE65–87
32. A.FedericiP.Giorgi RossiF.BartolozziS.FarchiP.BorgiaG.Guastcchi. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes Control2006; 17: 45–52.
33. C.SenoreP.ArmaroliM.Silvani. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation. Am J Gastroenterol2010; 105: 188–98.
34. G.VartR.BanziS.Minozzi. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med2012; 55: 87–92.
35. M.J.DentersM.DeutekomP.M.BossuytA.F.van RijnP.FockensE.Dekker. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening. Cancer Epidemiol2013; 37: 330–5.
36. F.ParenteC.BoemoA.Ardizzoia. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy2013; 45: 27–34.
37. S.CrottaN.SegnanS.PaganinB.DagnesR.RossetC.Senore. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol2012; 10: 633–8.
38. K.TifrateneF.EisingerY.RinaldiR.DidelotJ.F.Seitz. Colorectal cancer screening program: cost effectiveness of systematic recall letters. Gastroenterol Clin Biol2007; 31: 929–33.
39. B.DenisI.GendreE.A.SauleauJ.LacrouteP.Perrin. Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: a population-based cohort study. Dig Liv Dis2013; 45: 474–80.